330 related articles for article (PubMed ID: 11206411)
1. Lipid-dependent control of hepatic glycogen stores in healthy humans.
Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
[TBL] [Abstract][Full Text] [Related]
2. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
3. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
5. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
[TBL] [Abstract][Full Text] [Related]
6. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
[TBL] [Abstract][Full Text] [Related]
7. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
Chu CA; Galassetti P; Igawa K; Sindelar DK; Neal DW; Burish M; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
9. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
[TBL] [Abstract][Full Text] [Related]
10. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
[TBL] [Abstract][Full Text] [Related]
11. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile.
van Kempen AA; van der Crabben SN; Ackermans MT; Endert E; Kok JH; Sauerwein HP
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E723-30. PubMed ID: 16291574
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.
Diraison F; Large V; Brunengraber H; Beylot M
Diabetologia; 1998 Feb; 41(2):212-20. PubMed ID: 9498656
[TBL] [Abstract][Full Text] [Related]
14. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
[TBL] [Abstract][Full Text] [Related]
15. Parenteral glycerol enhances gluconeogenesis in very premature infants.
Sunehag AL
Pediatr Res; 2003 Apr; 53(4):635-41. PubMed ID: 12612213
[TBL] [Abstract][Full Text] [Related]
16. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.
Weghuber D; Mandl M; Krssák M; Roden M; Nowotny P; Brehm A; Krebs M; Widhalm K; Bischof MG
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1378-84. PubMed ID: 17785500
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver.
Nemecz M; Preininger K; Englisch R; Fürnsinn C; Schneider B; Waldhäusl W; Roden M
Hepatology; 1999 Jan; 29(1):166-72. PubMed ID: 9862863
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
[TBL] [Abstract][Full Text] [Related]
20. Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas.
Stingl H; Schnedl WJ; Krssak M; Bernroider E; Bischof MG; Lahousen T; Pacini G; Roden M
J Clin Endocrinol Metab; 2002 Oct; 87(10):4678-85. PubMed ID: 12364458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
